Trials that have a more heterogeneous study population are more generalisable to clinical practice and potentially have more external validity. However, because of a number of societal and historical factors, it is a challenge for trials to achieve this desired heterogeneous population.
Find out how leading experts from the clinical trial space are combating these challenges by listening to this webinar!
.jpg)
In this episode, I speak to Leigh Fell, CEO at Caritas Neuro Solutions, about carving your niche, the impact of work-life balance, the importance of psychedelic drug discovery and loads more. Click here to listen.
How can we improve diversity and access within the research space, particularly at site level? We asked some site managers in the know.
Are you attracting the very best industry talent to your start-up? For expert advice on how to thrive in today’s life science talent market, watch CM Life Science's latest 30-minute webinar. Click to watch.
Comments.